Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Lupin gains on arm listing NHI drug price for Bipresso extended release tablets

30-Aug2017

Lupin gains on arm listing NHI drug price for Bipresso extended release tablets

Lupin is currently trading at Rs. 992.95, up by 5.30 points or 0.54% from its previous closing of Rs. 987.65 on the BSE.

The scrip opened at Rs. 990.00 and has touched a high and low of Rs. 999.00 and Rs. 990.00 respectively. So far 8406 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1590.00 on 09-Sep-2016 and a 52 week low of Rs. 920.00 on 21-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1008.90 and Rs. 942.10 respectively. The current market cap of the company is Rs. 44953.82 crore.

The promoters holding in the company stood at 46.70%, while institutions and non-institutions held 40.66% and 12.63% respectively.

Lupin's Japanese subsidiary Kyowa Pharmaceutical Industry Co., has listed the NHI (National Health Insurance) drug price for Bipresso (generic name: Quetiapine Fumarate) extended release 50mg and 150 mg tablets for the treatment of depressive symptoms associated with bipolar disorder. NHI drug price are listed at 71.00 Yen per 50mg tablet and 188.60 Yen per 150mg tablet.

Astellas Pharma Inc. obtained approval for Bipresso Extended Release Tablets on July 3, 2017. Bipresso Extended Release Tablets contains the active ingredient quetiapine fumarate and is an extended-release tablet to be taken orally once a day. Based on the agreement between Astellas and Kyowa made in February 2017, Kyowa will distribute, sell and promote Bipresso Extended-Release Tablets exclusively in Japan.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Related News

View all news

SBI Life shines on reporting 15% rise in Q3 net profit

SBI Life Insurance Company is currently trading at Rs. 635.45, up by 15.65 points or 2.53% from its previous closing of Rs. 619.80 on the BSE.The scrip opened at Rs. 621.00 and has touched a high and low......

Reliance Industries zooms on the bourses

Reliance Industries is currently trading at Rs. 1219.00, up by 36.05 points or 3.05% from its previous closing of Rs. 1182.95 on the BSE.The scrip opened at Rs. 1193.90 and has touched a high and low of......

Infosys surges on the BSE

Infosys is currently trading at Rs. 746.30, up by 15.30 points or 2.09% from its previous closing of Rs. 731.00 on the BSE.The scrip opened at Rs. 733.00 and has touched a high and low of Rs. 750.70 and......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......